The MCF7-Ctrl and MCF7-TWIST1 cells used in this study represent a progression model from ER+/HER2− to ER−/HER2− breast cancer cells reprogrammed by TWIST1-induced EMT. The gene discussed is TWIST1; the disease is breast cancer.